ARCOSA INC (ACA) Stock Fundamental Analysis
USA - NYSE:ACA - US0396531008 - Common Stock
100.38 USD
-1.23 (-1.21%)
Taking everything into account, ACA scores 5 out of 10 in our fundamental rating. ACA was compared to 55 industry peers in the Construction & Engineering industry. ACA has an average financial health and profitability rating. ACA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
ACA had positive earnings in the past year.
ACA had a positive operating cash flow in the past year.
Each year in the past 5 years ACA has been profitable.
In the past 5 years ACA always reported a positive cash flow from operatings.
1.2 Ratios
ACA has a Return On Assets (1.84%) which is comparable to the rest of the industry.
The Return On Equity of ACA (3.68%) is worse than 60.00% of its industry peers.
The Return On Invested Capital of ACA (4.09%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 16.81%.
The last Return On Invested Capital (4.09%) for ACA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROIC | 4.09% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
1.3 Margins
ACA has a Profit Margin (3.45%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of ACA has declined.
With a decent Operating Margin value of 8.93%, ACA is doing good in the industry, outperforming 69.09% of the companies in the same industry.
In the last couple of years the Operating Margin of ACA has declined.
ACA has a Gross Margin of 20.82%. This is in the better half of the industry: ACA outperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of ACA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% |
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
2. Health
2.1 Basic Checks
ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACA has more shares outstanding
Compared to 5 years ago, ACA has more shares outstanding
The debt/assets ratio for ACA is higher compared to a year ago.
2.2 Solvency
ACA has an Altman-Z score of 2.26. This is not the best score and indicates that ACA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ACA (2.26) is comparable to the rest of the industry.
The Debt to FCF ratio of ACA is 5.72, which is a neutral value as it means it would take ACA, 5.72 years of fcf income to pay off all of its debts.
ACA has a Debt to FCF ratio (5.72) which is in line with its industry peers.
A Debt/Equity ratio of 0.67 indicates that ACA is somewhat dependend on debt financing.
ACA has a Debt to Equity ratio (0.67) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Altman-Z | 2.26 |
ROIC/WACC0.42
WACC9.74%
2.3 Liquidity
A Current Ratio of 2.12 indicates that ACA has no problem at all paying its short term obligations.
The Current ratio of ACA (2.12) is better than 89.09% of its industry peers.
ACA has a Quick Ratio of 1.35. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.35, ACA is in the better half of the industry, outperforming 67.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.03% over the past year.
The Earnings Per Share has been growing slightly by 5.16% on average over the past years.
Looking at the last year, ACA shows a quite strong growth in Revenue. The Revenue has grown by 11.35% in the last year.
Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.15% on average per year.
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
Revenue 1Y (TTM)11.35%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
3.2 Future
ACA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.31% yearly.
The Revenue is expected to grow by 7.30% on average over the next years.
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.56 indicates a quite expensive valuation of ACA.
Compared to the rest of the industry, the Price/Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 69.09% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ACA to the average of the S&P500 Index (25.91), we can say ACA is valued inline with the index average.
ACA is valuated rather expensively with a Price/Forward Earnings ratio of 21.37.
76.36% of the companies in the same industry are more expensive than ACA, based on the Price/Forward Earnings ratio.
ACA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 34.57, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.56 | ||
| Fwd PE | 21.37 |
4.2 Price Multiples
76.36% of the companies in the same industry are more expensive than ACA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ACA is valued cheaper than 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.73 | ||
| EV/EBITDA | 14.26 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ACA's earnings are expected to grow with 20.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.74
PEG (5Y)5.14
EPS Next 2Y24.91%
EPS Next 3Y20.31%
5. Dividend
5.1 Amount
With a yearly dividend of 0.20%, ACA is not a good candidate for dividend investing.
ACA's Dividend Yield is rather good when compared to the industry average which is at 1.78. ACA pays more dividend than 81.82% of the companies in the same industry.
With a Dividend Yield of 0.20, ACA pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
5.2 History
The dividend of ACA decreases each year by -0.48%.
ACA has been paying a dividend for over 5 years, so it has already some track record.
ACA has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-0.48%
Div Incr Years0
Div Non Decr Years5
5.3 Sustainability
ACA pays out 10.63% of its income as dividend. This is a sustainable payout ratio.
DP10.63%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
NYSE:ACA (11/14/2025, 2:44:14 PM)
100.38
-1.23 (-1.21%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners95.34%
Inst Owner Change-1.9%
Ins Owners1.8%
Ins Owner Change6.34%
Market Cap4.92B
Revenue(TTM)2.57B
Net Income(TTM)92.20M
Analysts86
Price Target118.32 (17.87%)
Short Float %2.38%
Short Ratio5.47
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.2% |
Yearly Dividend0.2
Dividend Growth(5Y)-0.48%
DP10.63%
Div Incr Years0
Div Non Decr Years5
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.94%
Min EPS beat(2)17.65%
Max EPS beat(2)162.24%
EPS beat(4)3
Avg EPS beat(4)36.02%
Min EPS beat(4)-40.32%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)29.61%
EPS beat(12)11
Avg EPS beat(12)31.83%
EPS beat(16)15
Avg EPS beat(16)40.43%
Revenue beat(2)1
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-3.72%
Max Revenue beat(2)1.83%
Revenue beat(4)1
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-7.1%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-0.98%
Revenue beat(12)7
Avg Revenue beat(12)0.67%
Revenue beat(16)11
Avg Revenue beat(16)2.34%
PT rev (1m)0%
PT rev (3m)3.73%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)3.96%
EPS NY rev (1m)1.84%
EPS NY rev (3m)6.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.6%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.56 | ||
| Fwd PE | 21.37 | ||
| P/S | 1.84 | ||
| P/FCF | 16.73 | ||
| P/OCF | 11.09 | ||
| P/B | 1.96 | ||
| P/tB | 5.86 | ||
| EV/EBITDA | 14.26 |
EPS(TTM)3.78
EY3.77%
EPS(NY)4.7
Fwd EY4.68%
FCF(TTM)6
FCFY5.98%
OCF(TTM)9.05
OCFY9.01%
SpS54.56
BVpS51.15
TBVpS17.14
PEG (NY)0.74
PEG (5Y)5.14
Graham Number65.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.84% | ||
| ROE | 3.68% | ||
| ROCE | 5.33% | ||
| ROIC | 4.09% | ||
| ROICexc | 4.27% | ||
| ROICexgc | 6.98% | ||
| OM | 8.93% | ||
| PM (TTM) | 3.45% | ||
| GM | 20.82% | ||
| FCFM | 11% |
ROA(3y)4.56%
ROA(5y)3.97%
ROE(3y)7.3%
ROE(5y)6.21%
ROIC(3y)3.99%
ROIC(5y)4.04%
ROICexc(3y)4.17%
ROICexc(5y)4.21%
ROICexgc(3y)7.17%
ROICexgc(5y)7.33%
ROCE(3y)5.21%
ROCE(5y)5.27%
ROICexgc growth 3Y4.01%
ROICexgc growth 5Y-10.09%
ROICexc growth 3Y4.98%
ROICexc growth 5Y-11.63%
OM growth 3Y11.96%
OM growth 5Y-2.91%
PM growth 3Y2.37%
PM growth 5Y-10.81%
GM growth 3Y3.69%
GM growth 5Y0.93%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 5.72 | ||
| Debt/EBITDA | 3.68 | ||
| Cap/Depr | 69.44% | ||
| Cap/Sales | 5.59% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.67% | ||
| Profit Quality | 319.09% | ||
| Current Ratio | 2.12 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 2.26 |
F-Score5
WACC9.74%
ROIC/WACC0.42
Cap/Depr(3y)104.81%
Cap/Depr(5y)89.02%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.15%
Profit Quality(3y)128.08%
Profit Quality(5y)133.99%
High Growth Momentum
Growth
EPS 1Y (TTM)17.03%
EPS 3Y16.17%
EPS 5Y5.16%
EPS Q2Q%71.43%
EPS Next Y36.06%
EPS Next 2Y24.91%
EPS Next 3Y20.31%
EPS Next 5YN/A
Revenue 1Y (TTM)11.35%
Revenue growth 3Y8.06%
Revenue growth 5Y8.15%
Sales Q2Q%24.58%
Revenue Next Year10.62%
Revenue Next 2Y8.3%
Revenue Next 3Y7.3%
Revenue Next 5YN/A
EBIT growth 1Y27.67%
EBIT growth 3Y20.99%
EBIT growth 5Y5.01%
EBIT Next Year133.35%
EBIT Next 3Y37.6%
EBIT Next 5YN/A
FCF growth 1Y717.22%
FCF growth 3Y56.55%
FCF growth 5Y2.7%
OCF growth 1Y103.53%
OCF growth 3Y44.47%
OCF growth 5Y6.95%
ARCOSA INC / ACA FAQ
Can you provide the ChartMill fundamental rating for ARCOSA INC?
ChartMill assigns a fundamental rating of 5 / 10 to ACA.
What is the valuation status for ACA stock?
ChartMill assigns a valuation rating of 6 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.
Can you provide the profitability details for ARCOSA INC?
ARCOSA INC (ACA) has a profitability rating of 5 / 10.
What are the PE and PB ratios of ARCOSA INC (ACA) stock?
The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 26.56 and the Price/Book (PB) ratio is 1.96.
What is the expected EPS growth for ARCOSA INC (ACA) stock?
The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 36.06% in the next year.